SE8703889L - Farmaceutiska kompositioner med fordrojd frigoring - Google Patents

Farmaceutiska kompositioner med fordrojd frigoring

Info

Publication number
SE8703889L
SE8703889L SE8703889A SE8703889A SE8703889L SE 8703889 L SE8703889 L SE 8703889L SE 8703889 A SE8703889 A SE 8703889A SE 8703889 A SE8703889 A SE 8703889A SE 8703889 L SE8703889 L SE 8703889L
Authority
SE
Sweden
Prior art keywords
pharmaceutical compositions
delayed release
active agent
aspirin
admixture
Prior art date
Application number
SE8703889A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE8703889D0 (sv
Inventor
H C Gan
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8703889D0 publication Critical patent/SE8703889D0/xx
Publication of SE8703889L publication Critical patent/SE8703889L/

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE8703889A 1986-10-09 1987-10-08 Farmaceutiska kompositioner med fordrojd frigoring SE8703889L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868624213A GB8624213D0 (en) 1986-10-09 1986-10-09 Sustained release pharmaceutical compositions

Publications (2)

Publication Number Publication Date
SE8703889D0 SE8703889D0 (sv) 1987-10-08
SE8703889L true SE8703889L (sv) 1988-04-10

Family

ID=10605478

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8703889A SE8703889L (sv) 1986-10-09 1987-10-08 Farmaceutiska kompositioner med fordrojd frigoring

Country Status (24)

Country Link
JP (1) JPS63101334A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR880004801A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU7942087A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE1000732A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1332809C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH675831A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3733540A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK527487A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2014518A6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI874414A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2604902B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (2) GB8624213D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR871550B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU201875B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL84104A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1221493B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU87009A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL8702294A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO874200L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ222083A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH24227A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT85880B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE8703889L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA877617B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
CN1208090C (zh) * 1999-03-31 2005-06-29 詹森药业有限公司 在控制释放制剂中的预胶凝淀粉
US6242003B1 (en) 2000-04-13 2001-06-05 Novartis Ag Organic compounds
US20060127474A1 (en) 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
SE0102886D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102888D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102887D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
TWI338583B (en) 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
CA2579220C (en) * 2004-09-09 2013-01-08 Psicofarma, S.A. De C.V. Pharmaceutical composition for the sustained release of hydralazine and use thereof as a support for cancer treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795766A (fr) * 1972-02-22 1973-08-22 Lilly Co Eli Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
DE3346571A1 (de) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen Oral retardierte acetylsalicylsaeureformulierungen
JPS61501511A (ja) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション 徐放性医薬カプセル

Also Published As

Publication number Publication date
HUT52958A (en) 1990-09-28
FI874414A0 (fi) 1987-10-07
FI874414L (fi) 1988-04-10
GB2195893A (en) 1988-04-20
NO874200D0 (no) 1987-10-07
LU87009A1 (fr) 1988-05-03
IL84104A0 (en) 1988-03-31
GB8723515D0 (en) 1987-11-11
NZ222083A (en) 1991-05-28
NO874200L (no) 1988-04-11
DK527487A (da) 1988-04-10
PT85880A (en) 1987-11-01
CH675831A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1990-11-15
SE8703889D0 (sv) 1987-10-08
JPS63101334A (ja) 1988-05-06
DE3733540A1 (de) 1988-04-14
FR2604902B1 (fr) 1991-04-26
PT85880B (pt) 1990-07-31
PH24227A (en) 1990-05-04
GB8624213D0 (en) 1986-11-12
BE1000732A5 (fr) 1989-03-21
CA1332809C (en) 1994-11-01
IT8748469A0 (it) 1987-10-08
NL8702294A (nl) 1988-05-02
ZA877617B (en) 1989-05-30
FR2604902A1 (fr) 1988-04-15
FI874414A7 (fi) 1988-04-10
HU201875B (en) 1991-01-28
GB2195893B (en) 1991-05-08
DK527487D0 (da) 1987-10-08
GR871550B (en) 1988-02-15
IT1221493B (it) 1990-07-06
AU7942087A (en) 1988-04-14
KR880004801A (ko) 1988-06-27
ES2014518A6 (es) 1990-07-16

Similar Documents

Publication Publication Date Title
DE69215612D1 (de) Verzögerte Freigabe-Matrix für Arzneimittel
NL194821B (nl) Farmacologisch actieve catecholderivaten en samenstellingen ervan.
ES8607009A1 (es) Un metodo para preparar una forma de dosificacion unitaria solida, terapeuticamente activa
DK86389A (da) Farmaceutisk granulat
SE8406081L (sv) Sett och komposition for framstellning av farmaceutiska preparat for oral administrering och med kontrollerad langtidsverkan
ATE77548T1 (de) Xanthangummienthaltende arzneimittelformulierung mit verzoegerter freisetzung.
MY101177A (en) Improvements in pharmaceutically acceptable salts
GB2200048B (en) Hydrosols of pharmacologically active agents and pharmaceutical compositions comprising them
NZ333247A (en) Granulate containing an active ingredient and a water dispersible cellulose useful for the preparation of fast-disintegrating and fast-dissolving compositions
LV10954A (lv) Benzimidazola atvasinajumi to iegusanas panemiens un tos saturosa farmaceitiska kompozicija
SE8703889L (sv) Farmaceutiska kompositioner med fordrojd frigoring
DK624287A (da) Komprimeret tablet eller kapsel
CO5070643A1 (es) Formulacion en tabletas comprimidas
ATE239709T1 (de) Racemisches huperzin a
CO4940406A1 (es) Composiciones de paracetamol de accion rapida
SE8704240D0 (sv) Analgesic preparations
IT9048102A0 (it) Derivati oligopeptidici dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono
TR199900013T2 (xx) Yeni bile�ikler.
RU2001120110A (ru) Фармацевтическая смесь, содержащая профен
NZ509593A (en) Compressed compositions comprising clarified xanthan gum
KR920000316A (ko) 젬피브로질 제제
DK0483320T3 (da) Farmaceutiske sammensætninger med forlænget frigivelse til peroral indgivelse og fremgangsmåde til fremstilling deraf
ATE102934T1 (de) Fluorierte flavon-essigsaeure.
ES2033512T3 (es) Composicion antiastenica, su procedimiento de preparacion y su utilizacion.
FR2449450A1 (fr) Nouvelles compositions pharmaceutiques utilisables pour le traitement de l'hypertension

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8703889-9

Effective date: 19920501

Format of ref document f/p: F